We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ERAS market cap is 380.74M. The company's latest EPS is USD -0.8276 and P/E is -3.07.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -138.08M | -37.03M | -35.97M | -34.66M | -33.87M |
| Net Income | -135.25M | -33.2M | -31.78M | -30.36M | -29.7M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -109.25M | -124.88M | -247.45M | -141.53M |
| Net Income | -101.66M | -122.76M | -242.81M | -125.04M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 514.91M | 467.54M | 440.66M | 419.41M | 395.3M |
| Total Liabilities | 103.06M | 81.09M | 77.96M | 80.43M | 78.61M |
| Total Equity | 411.85M | 386.45M | 362.71M | 338.98M | 316.69M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 124.83M | 501.42M | 514.91M | 395.3M |
| Total Liabilities | 17.4M | 44.89M | 103.06M | 78.61M |
| Total Equity | -113.98M | 456.53M | 411.85M | 316.69M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -103.26M | -26.36M | -52.31M | -76.43M | -101.22M |
| Investing | -71.08M | 14.71M | -93.95M | -95.77M | -91.22M |
| Financing | 98.08M | 183k | 832k | 839k | 1.3M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.69M | -79.6M | -103.26M | -101.22M |
| Investing | -71.2M | -64.59M | -71.08M | -91.22M |
| Financing | 139.99M | 439.4M | 98.08M | 1.3M |
| Market Cap | 380.74M |
| Price to Earnings Ratio | -3.07 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.12 |
| Price to Book Ratio | 1.21 |
| Dividend Yield | - |
| Shares Outstanding | 151.09M |
| Average Volume (1 week) | 4M |
| Average Volume (1 Month) | 3.34M |
| 52 Week Change | -3.82% |
| 52 Week High | 3.375 |
| 52 Week Low | 1.51 |
| Spread (Intraday) | 0.07 (2.7%) |
| Company Name | Erasca Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.erasca.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
